Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS1 | P29475 | 2/20 | 0.36 |
| ▸ | NOS2 | P35228 | 2/20 | 0.36 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.32 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.32 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.32 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.32 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.32 |
| ▸ | FAAH | O00519 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1645972 | 0.77 | FAAH (0.40) | NOS1NOS2CHRNB2CHRNB4CHRNA3 | |
| SCHEMBL4344754 | 0.76 | NOS1 (0.35) | NOS1NOS2 | |
| SCHEMBL4353543 | 0.74 | — | — | |
| SCHEMBL4349647 | 0.72 | NOS1 (0.30) | NOS1NOS2 | |
| SCHEMBL18093606 | 0.67 | NOS1 (0.41) | NOS1NOS2CHRNB2CHRNB4CHRNA3 | |
| SCHEMBL14483980 | 0.67 | FAAH (0.35) | NOS1NOS2CHRNB2CHRNB4CHRNA3 | |
| SCHEMBL360776 | 0.61 | FAAH (0.40) | NOS1NOS2CHRNB2CHRNB4CHRNA3 | |
| SCHEMBL169033 | 0.61 | CYP3A4 (0.44) | NOS1NOS2CHRNB2CHRNB4CHRNA3 | |
| SCHEMBL26361631 | 0.60 | FAAH (0.39) | NOS1NOS2CHRNB2CHRNB4CHRNA3 | |
| SCHEMBL3637263 | 0.60 | NOS1 (0.46) | NOS1NOS2FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1361246-B1 | ORGANIC POLYMER AND NOVEL POLYMERIZABLE COMPOUND | MITSUI CHEMICALS INC (JP) | 2009-02-18 | — | — | EP | disclosed |
| US-6797805-B2 | Organic polymers and novel polymerizable compounds | MITSUI CHEMICALS, INC. (JP) | 2004-09-28 | — | — | US | disclosed |
| EP-1361246-A1 | ORGANIC POLYMER AND NOVEL POLYMERIZABLE COMPOUND | Mitsui Chemicals, Inc. (JP) | 2003-11-12 | — | — | EP | disclosed |
| US-20030166808-A1 | Organic polymers and novel polymerizable compound | MITSUI CHEMICALS, INC. (JP) | 2003-09-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030166808-A1 | Organic polymers and novel polymerizable compound | PCNA, UTP18, ODC1 | NOS1 853/4885NOS2 523/4885CHRNB2 4080/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.